Schizophrenia. Schizophrenia
Conditions
Interventions
Intervention 1: Intervention group: Atomoxetine is given 40 mg daily in the first week and 80 mg daily in the following weeks until 8 weeks. The effect of the medication on the negative symptoms in th
Sponsors
Ahvaz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: Detection of schizophrenia based on the diagnosis of a faculty psychiatrist and an psychiatrist assistant with a clinical interview based on DSM-5 Bold negative symptoms( PANSS negative symptom sub-scale score more than 15) Not having liver disease Suffering from the disease for more than a year Age between 18 and 70 years.
Exclusion criteria
Exclusion criteria: Presence of Depression based on DSM-5 Clinical Interview Presence of Bipolar disorder Pregnant or lactating woman Substance abuse during the last month patients suffering from Attention Deficit Hyperactivity Disorder (ADHD)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Lack of social interest. Timepoint: At the beginning of the treatment and at 4th and 8th weeks. Method of measurement: PANSS scale.;Frivolity. Timepoint: At the beginning of the treatment and at 4th and 8th weeks. Method of measurement: PANSS scale.;Anhedonia. Timepoint: At the beginning of the treatment and at 4th and 8th weeks. Method of measurement: PANSS scale.;Loss of motivation. Timepoint: At the beginning of the treatment and at 4th and 8th weeks. Method of measurement: PANSS scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactForough Riahi
Ahvaz University of Medical Sciences
Outcome results
None listed